Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. (APGE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
apge · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$140
Consensus
$111
+30.9% upside
Low
$81.00
Median: $103 · Last Close: $84.77
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$111.00
30.9% upside
High Target
$140
65.2%
Low Target
$81
-4.4%
Current Price
$84.77
as of today
Based on analyst price targets, the APGE stock price prediction for the next 12 months ranges from $81 to $140. The consensus APGE price forecast of $111.00 implies 30.9% upside from the current price of $84.77.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $87.46 | ↑ 3.18% |
1-day model range: $86.93–$87.99. Peak: $87.99 (+3.18%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $150 | +76.4% |
| 2028 | $218 | +157.3% |
| 2029 | $278 | +228.0% |
| 2030 | $324 | +282.2% |
| 2031 | — | +320.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · APGE · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | Truist Securities | Maintains | Hold→Hold |
| 2026-05-27 | BTIG | Maintains | Buy→Buy |
| 2026-05-27 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-30 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-24 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-24 | Citigroup | Maintains | Buy→Buy |
| 2026-03-23 | BTIG | Maintains | Buy→Buy |
| 2026-03-16 | BTIG | Maintains | Buy→Buy |
| 2026-03-03 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Apogee Therapeutics, Inc. (APGE) stock. Of the recent 28 rating actions, 0 were upgrades and 1 were downgrades. 11 analysts currently cover APGE.
Analyst Recommendation Trends
APGE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$14M
↓ 79.6% YoY
Revenue Next Year
$13M
↓ 12.5% YoY
EPS This Year
$-4.40
EPS Next Year
$-5.35
↑ 21.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast APGE EPS of $-4.40 for the current fiscal year, based on estimates from 11 analysts. The APGE revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The APGE stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus APGE price target is $111.00 (+30.9% upside), with an analyst consensus of Buy.
The APGE short-term stock prediction for tomorrow is $87.46 (+3.18%). The APGE stock price prediction for 2027 estimates an average of $150. The APGE stock prediction for 2030 projects a range of $302–$346.
Apogee Therapeutics, Inc. trades on NASDAQ under the ticker APGE. The APGE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.
Frequently asked questions
APGE forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month APGE price target is $111.00, with a high forecast of $140.00 and a low of $81.00. The median price target is shown in the chart above when available. This implies +30.9% potential upside from the current price of $84.77.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.